RRMM, Carfilzomib, Ixazomib, MyDRUG Trial

RRMM, Carfilzomib, Ixazomib, MyDRUG Trial

User Photo
HMP CME

1 year
138 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ken Anderson M.D., Director of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute (DFCI) Discusses RRMM, Carfilzomib, Ixazomib, MyDRUG Trial at Lymphoma & Myeloma on October 18, 2018.
Up Next Autoplay